N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine

C82H76Cl3F8IN16O11 — CID 159232906

IUPACN-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine
SMILESCC(F)(F)C(=O)N[C@H]1CC(=O)N[C@@H]1c1cccc(Cl)c1.CC(F)(F)C(=O)O.CN.Cn1cc(-n2ncc3cc(I)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@@H](NC(=O)C(C)(F)F)[C@@H]4c4cccc(Cl)c4)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@H](NC(=O)C(C)(F)F)[C@H]4c4cccc(Cl)c4)ccc32)ccc1=O
InChIInChI=1S/2C26H22ClF2N5O3.C13H13ClF2N2O2.C13H10IN3O.C3H4F2O2.CH5N/c2*1-26(28,29)25(37)31-20-12-23(36)33(24(20)15-4-3-5-17(27)10-15)18-6-8-21-16(11-18)13-30-34(21)19-7-9-22(35)32(2)14-19;1-13(15,16)12(20)17-9-6-10(19)18-11(9)7-3-2-4-8(14)5-7;1-16-8-11(3-5-13(16)18)17-12-4-2-10(14)6-9(12)7-15-17;1-3(4,5)2(6)7;1-2/h2*3-11,13-14,20,24H,12H2,1-2H3,(H,31,37);2-5,9,11H,6H2,1H3,(H,17,20)(H,18,19);2-8H,1H3;1H3,(H,6,7);2H2,1H3/t2*20-,24+;9-,11+;;;/m100.../s1
InChIKeyKTCXJDCTGQKKFO-VFSMRFKRSA-N
MW1846.86 g/mol
LogP12.66
Rot. Bonds15

About N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine

N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine (PubChem CID 159232906) has the molecular formula C82H76Cl3F8IN16O11 and a molecular weight of 1846.86 g/mol. Its IUPAC name is N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine.

Molecular Properties

Compound NameN-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine
PubChem CID159232906
Molecular FormulaC82H76Cl3F8IN16O11
Molecular Weight1846.86 g/mol
Exact Mass1844.39
IUPAC NameN-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine
SMILESCC(F)(F)C(=O)N[C@H]1CC(=O)N[C@@H]1c1cccc(Cl)c1.CC(F)(F)C(=O)O.CN.Cn1cc(-n2ncc3cc(I)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@@H](NC(=O)C(C)(F)F)[C@@H]4c4cccc(Cl)c4)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@H](NC(=O)C(C)(F)F)[C@H]4c4cccc(Cl)c4)ccc32)ccc1=O
InChIInChI=1S/2C26H22ClF2N5O3.C13H13ClF2N2O2.C13H10IN3O.C3H4F2O2.CH5N/c2*1-26(28,29)25(37)31-20-12-23(36)33(24(20)15-4-3-5-17(27)10-15)18-6-8-21-16(11-18)13-30-34(21)19-7-9-22(35)32(2)14-19;1-13(15,16)12(20)17-9-6-10(19)18-11(9)7-3-2-4-8(14)5-7;1-16-8-11(3-5-13(16)18)17-12-4-2-10(14)6-9(12)7-15-17;1-3(4,5)2(6)7;1-2/h2*3-11,13-14,20,24H,12H2,1-2H3,(H,31,37);2-5,9,11H,6H2,1H3,(H,17,20)(H,18,19);2-8H,1H3;1H3,(H,6,7);2H2,1H3/t2*20-,24+;9-,11+;;;/m100.../s1
InChIKeyKTCXJDCTGQKKFO-VFSMRFKRSA-N
XLogP12.66
TPSA339.80 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds15
Heavy Atoms121
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001846.86
LogP ≤ 512.66
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine?
The IUPAC name of N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine (CID 159232906) is N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine.
What is the SMILES notation for N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine?
The canonical SMILES for N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine is CC(F)(F)C(=O)N[C@H]1CC(=O)N[C@@H]1c1cccc(Cl)c1.CC(F)(F)C(=O)O.CN.Cn1cc(-n2ncc3cc(I)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@@H](NC(=O)C(C)(F)F)[C@@H]4c4cccc(Cl)c4)ccc32)ccc1=O.Cn1cc(-n2ncc3cc(N4C(=O)C[C@H](NC(=O)C(C)(F)F)[C@H]4c4cccc(Cl)c4)ccc32)ccc1=O.
What is the InChIKey of N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine?
The InChIKey is KTCXJDCTGQKKFO-VFSMRFKRSA-N. The full InChI is InChI=1S/2C26H22ClF2N5O3.C13H13ClF2N2O2.C13H10IN3O.C3H4F2O2.CH5N/c2*1-26(28,29)25(37)31-20-12-23(36)33(24(20)15-4-3-5-17(27)10-15)18-6-8-21-16(11-18)13-30-34(21)19-7-9-22(35)32(2)14-19;1-13(15,16)12(20)17-9-6-10(19)18-11(9)7-3-2-4-8(14)5-7;1-16-8-11(3-5-13(16)18)17-12-4-2-10(14)6-9(12)7-15-17;1-3(4,5)2(6)7;1-2/h2*3-11,13-14,20,24H,12H2,1-2H3,(H,31,37);2-5,9,11H,6H2,1H3,(H,17,20)(H,18,19);2-8H,1H3;1H3,(H,6,7);2H2,1H3/t2*20-,24+;9-,11+;;;/m100.../s1.
What are the key properties of N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine?
N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine has a molecular weight of 1846.86 g/mol, XLogP of 12.66, 15 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,3R)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-1-[1-(1-methyl-6-oxo-3-pyridinyl)indazol-5-yl]-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;N-[(2R,3S)-2-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-2,2-difluoropropanamide;2,2-difluoropropanoic acid;5-(5-iodoindazol-1-yl)-1-methylpyridin-2-one;methanamine is sourced from PubChem (CID 159232906), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).